| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2003; 42: 491
© 2003 British Society for Rheumatology
Letters to the Editor |
Pamidronate for SAPHO syndrome
Addenbrooke's Hospital, Cambridge, UK
SIR, Marshall et al. [1] propose pamidronate as a novel treatment for SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) but we reported effective relief of pain for 3 months with a single infusion of 60 mg pamidronate in a patient under my care in a series of four patients in 1993 [2]. I prefer the term arthro-osteitis' to SAPHO syndrome as synovitis, acne and pustulosis are not sine qua non features of this rare condition. Pamidronate can be repeated safely when pain recurs, and it has become a useful treatment.
Notes
E-mail: ajcrisp{at}addenbrookes.nhs.uk ![]()
References
- Marshall H, Bromilow J, Thomas AL, Arden NK. Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 2002;41:2313.
[Free Full Text] - Watts RA, Crisp AJ, Daunt SO'N, Hazleman BL, Jenner JR. Arthro-osteitis: a clinical spectrum. Br J Rheumatol 1993;32:4037.
[Abstract/Free Full Text]
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||